IJSER Home >> Journal >> IJSER
International Journal of Scientific and Engineering Research
ISSN Online 2229-5518
ISSN Print: 2229-5518 8    
Website: http://www.ijser.org
scirp IJSER >> Volume 3,Issue 8,August 2012
Community Perception on the Use of Over the Counter (OTC) Medications in Malaysia
Full Text(PDF, )  PP.200-203  
Amuthaganesh Mathialagan, Simreet Kaur
Non-prescription medicines, over the counter drugs, public opinion, survey
Over the counter (OTC) medications use for self medication is progressively increasing, but such medications are also liable for abuse and misuse. The aim of this study is to determine community views on use of OTC medicines. A cross-sectional study design was used to achieve the objectives of the study. Data were collected using a survey administered to I000 members of the public in 5 different states of Malaysia. Data were coded and entered into a custom designed SPSS database for statistical analysis. Majority of the participants (60.4%) did not take regular prescription medications. Those without any long term illness, health problem or disability (60.4%) were the ones who took prescription medication regularly. Almost half of the participants (40.8%) reported visiting the community pharmacy less than monthly and 30.3% reported that a pharmacist influenced their choice of medication being purchased. The general public in Malaysia is highly aware that non-prescription medications could be abused. This survey discovered that the general public had a high level of awareness of the abuse potential of OTC medications and that pharmacist's recommendation influenced their choice. This indicates that in case of inappropriate OTC drug use management, a pharmacist should be given a more significant role to play.
[1] S. Rina, M. Monti, A. Antonietti. J. Dovepress: Advances in Medical Education and Practice. 2: 59-70 (2011)

[2] Legal Research Board of Malaysia, Malaysian laws on poison and sales of drugs, Kuala Lumpur: International Law Books Services, (2006) pp. 33–80.

[3] D.W. Kaufman, J.P. Kelly, L. Rosenberg , T.E. Anderson, A.A. Mitchell, J. Am Med Assoc. 287: 337–344 (2002)

[4] S. Sihvo, T. Klaukka, J. Martikainen, E. Hemminki, J. Eur Clin Pharmacol. 56: 495–499 (2002)

[5] P.K. Honig, L.R. Cantilena, J. Clin Pharmacokinet. 26: 85–90 (1994)

[6] C. Anderson. Health promotion in community pharmacy: the UK situation. Patient Educ Couns, (2000) Vol. 39, pp. 285-291.

[7] I. Krass, F. Hourihan, T.Chen. J Health Promot Aust. 14: 101- 107 (2003)

[8] J.A. Mayer, L. Eckhardt, B.M. Stepanski, J.F. Sallis, J.P. Elder, D.J. Slymen. J Am Public health. 88: 1096-1099 (1998).

[9] S.I. Benrimoj, M.S. Frommer. Community pharmacy in Australia, Aust HealthRev, (2004) Vol. 28, pp. 238-46.

[10] M.A. Hassali, A. Awaisu, A.A. Shafie, M.S. Saeed. Malaysian Family Physician. (2009), Vol. 4.

[11] W.A. Zellmer. J .Am Hosp Pharm. 48:1453 (1991)

[12] C. Anderson. J Soc Admin Pharm. 15:10–22 (1998)

[13] H. Bell, J. McElnay, C. Hughes, J. Soc Adm Pharm. 17: 119–128 (2000)

[14] P.K. Honig, B.K. Gillespie, J. Drug Saf. 13: 296–303 (1995)

[15] A. Dedy, S. Azmi . Archives of Pharmacy Practice. (2011), Vol. 2(3), pp. 95- 100.

[16] D. Douglas, B.F. Rybeck, T.S. Tracy. J. Am Obstet Gynecol. 190: 351-357 (2004)

[17] B. Sleath, R.H. Rubin, W. Campbell, L. Gwyther, T. Clark . Soc Sci Med. 53: 357-369 (2001)

[18] D.W. Kaufman, J.P. Kelly, L. Rosenberg, T.E. Anderson, A.A. Mitchell, J. of the American Medical Association. 287(3):337-344 (2001)

Untitled Page